Predictors of vancomycin-resistant enterococcus (VRE) carriage in the first major VRE outbreak in Singapore

Annals of the Academy of Medicine Singapore

Volumn 36, Issue 6, 2007, Pages 379-383

  Yang, Kok Soong ^a   Fong, Yuke Tien ^a   Lee, Heow Yong ^a   Kurup, Asok ^a   Koh, Tse Hsien ^a   Koh, David ^b   Lim, Meng Kin ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Colonisation; Hospital acquired; Infection

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CLINICAL EXAMINATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; ENTEROCOCCAL INFECTION; ENTEROCOCCUS; EPIDEMIC; FEMALE; HIGH RISK POPULATION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; PREDICTION; RISK ASSESSMENT; SEX DIFFERENCE; SINGAPORE; TERTIARY HEALTH CARE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 34547816080     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Willems RJ, Top J, van Santen M, Robinson DA, Coque TM, Baquero F, et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005;11:821-8.
2. Bonten MJ, Willems R, Weinstein RA. Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001;1:314-25.
3. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003;24:362-86.
4. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158:1127-32.
5. Austin DJ, Bonten MJ, Weinstein RA, Slaughter S, Anderson RM. Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A 1999;96:6908-13.
6. Ridwan B, Mascini E, van Der Reijden N, Verhoef J, Bonten M. What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals? BMJ 2002;324:666-8.
7. Centers for Disease Control and Prevention (CDC). Vancomycin-Resistant Staphylococcus aureus - New York, 2004. MMWR Morb Mortal Wkly Rep 2004;53;322-3.
8. Centers for Disease Control and Prevention (CDC). Vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep 2002;51:902.
9. Centers for Disease Control and Prevention (CDC). Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002;51:565-7.
10. Padiglione AA, Wolfe R, Grabsch EA, Olden D, Pearson S, Franklin C, et al. Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures. Antimicrob Agents Chemother 2003;47:2492-8.
11. Beltrami EM, Singer DA, Fish L, Manning K, Young S, Banerjee SN, et al. Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak. Am J Infect Control 2000;28:282-5.
12. Timmers GJ, van der Zwet WC, Simoons-Smit IM, Savelkoul PH, Meester HH, Vandenbroucke-Grauls CM, et al. Outbreak of vancomycin-resistant Enterococcus faecium in a haematology unit: risk factor assessment and successful control of the epidemic. Br J Haematol 2002;116:826-33.
13. Furuno JP, Harris AD, Wright MO, McGregor JC, Venezia RA, Zhu J, et al. Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission. Am J Infect Control 2004;32:436-40.
14. Lee TA, Hacek DM, Stroupe KT, Collins SM, Peterson LR. Three surveillance strategies for vancomycin-resistant enterococci in hospitalized patients: detection of colonization efficiency and a cost-effectiveness model. Infect Control Hosp Epidemiol 2005;26:39-46.
15. Husni R, Hachem R, Hanna H, Raad I. Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol 2002;23:102-3.
16. Hachem R, Graviss L, Hanna H, Arbuckle R, Dvorak T, Hackett B, et al. Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy. Infect Control Hosp Epidemiol 2004;25:391-4.
17. Duckro AN, Blom DW, Lyle EA, Weinstein RA, Hayden MK. Transfer of vancomycin-resistant enterococci via health care worker hands. Arch Intern Med 2005;165:302-7.
18. Perencevich EN, Fisman DN, Lipsitch M, Harris AD, Morris JG Jr, Smith DL. Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units. Clin Infect Dis 2004;38:1108-15.
19. Ostrowsky BE, Trick WE, Sohn AH, Quirk SB, Holt S, Carson LA, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001 10;344:1427-33.
20. Christiansen KJ, Tibbett PA, Beresford W, Pearman JW, Lee RC, Coombs GW, et al. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol 2004;25:384-90.
21. Ridwan B, Mascini E, van Der Reijden N, Verhoef J, Bonten M. What action should be taken to prevent spread of vancomycin-resistant enterococci in European hospitals? BMJ 2002;324:666-8.
22. Murray PR. Manual of Clinical Microbiology. 8th ed. Washington, DC: ASM Press, 2003.
23. Oon LL, Ling MM, Chiew YF. Gastrointestinal colonisation of vancomycin-resistant enterococcus in a Singapore teaching hospital. Pathology 2001;33:216-21.